Revelation Biosciences (REVB) Enterprise Value (2020 - 2026)
Revelation Biosciences' Enterprise Value came in at -$7.47 million for Q2 2026, compared with -$3.39 million a year earlier.
Powered by 
Analysis
Revelation Biosciences (REVB) Enterprise Value (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Revelation Biosciences reported Enterprise Value of -$45 million; for FY2025, it came in at -$8.71 million.
- Going back by year, Enterprise Value was -$5.23 million in FY2024, -$8.02 million in FY2023, $102.27 million in FY2022 (-99.5%) and $19.49 billion in FY2021 (-57.8%).
- The five-year range for quarterly Enterprise Value is -$11.61 million (Q1 2024) to $19.49 billion (Q4 2021).
- Across the past five years, year-over-year decline in Enterprise Value ran from 5.4% in Q1 2022 to 99.6% in Q1 2023.
- Business Quant data shows REVB's Enterprise Value at -$10.26 million (Q1 2026), -$8.71 million (Q4 2025) and -$8.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Revelation Biosciences | 3.36 Mn | -45.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.47 Mn |
| Mar 31, 2026 | -10.26 Mn |
| Dec 31, 2025 | -8.71 Mn |
| Sep 30, 2025 | -8.95 Mn |
| Jun 30, 2025 | -3.39 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | -5.23 Mn |
| Sep 30, 2024 | -4.26 Mn |
| Jun 30, 2024 | -8.96 Mn |
| Mar 31, 2024 | -11.61 Mn |
| Dec 31, 2023 | -8.02 Mn |
| Sep 30, 2023 | 116.16 Mn |
| Jun 30, 2023 | 161.87 Mn |
| Mar 31, 2023 | 68.51 Mn |
| Dec 31, 2022 | 102.27 Mn |
| Sep 30, 2022 | 180.96 Mn |
| Jun 30, 2022 | 510.96 Mn |
| Mar 31, 2022 | 18.05 Bn |
| Dec 31, 2021 | 19.49 Bn |
| Sep 30, 2021 | 19.26 Bn |
API Access
Revelation Biosciences Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();